547 related articles for article (PubMed ID: 25412681)
1. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
3. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants.
Potsiurko S; Dobryanskyy D; Sekretar L; Salabay Z
Am J Perinatol; 2024 Apr; 41(6):730-738. PubMed ID: 35213904
[TBL] [Abstract][Full Text] [Related]
4. Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.
Edstedt Bonamy AK; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M;
Neonatology; 2017; 111(4):367-375. PubMed ID: 28125815
[TBL] [Abstract][Full Text] [Related]
5. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
7. The importance of echocardiography and an individual approach to patent ductus arteriosus treatment in extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(4):257. PubMed ID: 25720362
[No Abstract] [Full Text] [Related]
8. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
[TBL] [Abstract][Full Text] [Related]
9. Future Benefits of Sequential Echocardiography: Unmasking the Indications for Treatment of Patent Ductus Arteriosus in Extremely Preterm Infants.
Olsson KW; Sindelar R
Neonatology; 2015; 108(2):99. PubMed ID: 26068311
[No Abstract] [Full Text] [Related]
10. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
Hundscheid T; Onland W; van Overmeire B; Dijk P; van Kaam AHLC; Dijkman KP; Kooi EMW; Villamor E; Kroon AA; Visser R; Vijlbrief DC; de Tollenaer SM; Cools F; van Laere D; Johansson AB; Hocq C; Zecic A; Adang E; Donders R; de Vries W; van Heijst AFJ; de Boode WP
BMC Pediatr; 2018 Aug; 18(1):262. PubMed ID: 30077184
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.
Gulack BC; Laughon MM; Clark RH; Sankar MN; Hornik CP; Smith PB
Early Hum Dev; 2015 Dec; 91(12):725-9. PubMed ID: 26386610
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.
Boghossian NS; Do BT; Bell EF; Dagle JM; Brumbaugh JE; Stoll BJ; Vohr BR; Das A; Shankaran S; Sanchez PJ; Wyckoff MH; Bethany Ball M;
Early Hum Dev; 2017 Oct; 113():10-17. PubMed ID: 28697406
[TBL] [Abstract][Full Text] [Related]
14. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.
Hundscheid T; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Dijkman KP; van Kaam AH; Villamor E; Kroon AA; Visser R; Mulder-de Tollenaer SM; De Bisschop B; Dijk PH; Avino D; Hocq C; Zecic A; Meeus M; de Baat T; Derriks F; Henriksen TB; Kyng KJ; Donders R; Nuytemans DHGM; Van Overmeire B; Mulder AL; de Boode WP;
N Engl J Med; 2023 Mar; 388(11):980-990. PubMed ID: 36477458
[TBL] [Abstract][Full Text] [Related]
15. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age.
Clyman RI; Liebowitz M; Kaempf J; Erdeve O; Bulbul A; Håkansson S; Lindqvist J; Farooqi A; Katheria A; Sauberan J; Singh J; Nelson K; Wickremasinghe A; Dong L; Hassinger DC; Aucott SW; Hayashi M; Heuchan AM; Carey WA; Derrick M; Fernandez E; Sankar M; Leone T; Perez J; Serize A;
J Pediatr; 2019 Feb; 205():41-48.e6. PubMed ID: 30340932
[TBL] [Abstract][Full Text] [Related]
16. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
[TBL] [Abstract][Full Text] [Related]
17. Adequate timely treatment of patent ductus arteriosus in extremely low birth weight infants: an ongoing challenge.
Meyer S
Neonatology; 2015; 107(4):256. PubMed ID: 25721918
[No Abstract] [Full Text] [Related]
18. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
[TBL] [Abstract][Full Text] [Related]
19. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
Adamska E
Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
[TBL] [Abstract][Full Text] [Related]
20. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
